Search research articles
Contact Us
Filters
Showing results (571-580 of 642) with videos related to
Page
of 65
Sort By:
American Heart Journal
|
March 8, 2024
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial
Mitchell Krucoff, Alessandro Spirito, Usman Baber, et al.
Journal of Clinical Medicine
|
August 23, 2020
Evaluation of Myocardial Gene Expression Profiling for Superior Diagnosis of Idiopathic Giant-Cell Myocarditis and Clinical Feasibility in a Large Cohort of Patients with Acute Cardiac Decompensation
Felicitas Escher, Heiko Pietsch, Ganna Aleshcheva, et al.
American Heart Journal
|
September 2, 2020
Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease
Barbara E Stähli, Ferdinando Varbella, Bettina Schwarz, et al.
Journal of the American College of Cardiology
|
November 12, 2013
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)
David J Whellan, Pierluigi Tricoci, Edmond Chen, et al.
American Heart Journal
|
February 28, 2016
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation
Vincent Johan Nijenhuis, Naoual Bennaghmouch, Mariella Hassell, et al.
JAMA Cardiology
|
May 15, 2021
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial
Birgit Vogel, Usman Baber, David J Cohen, et al.
European Journal of Preventive Cardiology
|
June 4, 2019
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome
Alberto Aimo, James L Januzzi, Giuseppe Vergaro, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY
Sergio Leonardi, Mattia Branca, Anna Franzone, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 11, 2021
Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data
Nick Marcks, Alberto Aimo, James L Januzzi, et al.
The New England Journal of Medicine
|
October 31, 2017
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock
Holger Thiele, Ibrahim Akin, Marcus Sandri, et al.
Page
of 65
Search research articles
Search
Showing results (571-580 of 642) with videos related to
Sort By:
Page
of 65
American Heart Journal
|
March 8, 2024
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial
Mitchell Krucoff, Alessandro Spirito, Usman Baber, et al.
Journal of Clinical Medicine
|
August 23, 2020
Evaluation of Myocardial Gene Expression Profiling for Superior Diagnosis of Idiopathic Giant-Cell Myocarditis and Clinical Feasibility in a Large Cohort of Patients with Acute Cardiac Decompensation
Felicitas Escher, Heiko Pietsch, Ganna Aleshcheva, et al.
American Heart Journal
|
September 2, 2020
Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease
Barbara E Stähli, Ferdinando Varbella, Bettina Schwarz, et al.
Journal of the American College of Cardiology
|
November 12, 2013
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)
David J Whellan, Pierluigi Tricoci, Edmond Chen, et al.
American Heart Journal
|
February 28, 2016
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation
Vincent Johan Nijenhuis, Naoual Bennaghmouch, Mariella Hassell, et al.
JAMA Cardiology
|
May 15, 2021
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial
Birgit Vogel, Usman Baber, David J Cohen, et al.
European Journal of Preventive Cardiology
|
June 4, 2019
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome
Alberto Aimo, James L Januzzi, Giuseppe Vergaro, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY
Sergio Leonardi, Mattia Branca, Anna Franzone, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 11, 2021
Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data
Nick Marcks, Alberto Aimo, James L Januzzi, et al.
The New England Journal of Medicine
|
October 31, 2017
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock
Holger Thiele, Ibrahim Akin, Marcus Sandri, et al.
Page
of 65